APPLICATION OF A FLUOROGENIC SUBSTRATE IN THE ASSAY OF PROTEOLYTIC ACTIVITY AND IN THE DISCOVERY OF A POTENT INHIBITOR OF CANDIDA-ALBICANS ASPARTIC PROTEINASE

被引:44
作者
CAPOBIANCO, JO
LERNER, CG
GOLDMAN, RC
机构
[1] Anti-Infective Research Division, Department 47M, Abbott Laboratories, Abbott Park, IL 60064-3500, Building AP9A, One Abbott Park Road
关键词
D O I
10.1016/0003-2697(92)90145-W
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A fluorescent method for monitoring the activity of the secreted Candida carboxyl (aspartic) proteinase (EC 3.4.23.6) was developed using a fluorogenic substrate based on resonance energy transfer. The fluorescent assay was used to monitor proteinase production, purification, and inhibition. The Km for the fluorogenic substrate, 4-(4-dimethylaminophenylazo)benzoyl-γ-aminobutyryl-Ile-His-Pro-Phe-His-Leu-Val-Ile-His - Thr - [5 - (2 - aminoethyl)amino]naphthalene - 1 -sulfonic acid, was found to be 4.3 μm at the optimum pH of 4.5. Reaction products were separated by reversephase high-performance liquid chromatography and identified by amino acid analysis or by 252Cf plasma desorption mass spectrometry. Cleavage of the fluorogenic substrate was between the histidine-threonine residues, releasing the fluorescent product, threonine-[5-(2-aminoethyl)amino]naphthalene-1-sulfonic acid. Proteolytic activity was expressed as nanomoles of fluorescent product released at 22°C/60 min, pH 4.5, and the release of 0.9 nmol product was equivalent to one hemoglobin proteolytic unit (O.D.A700 increase of 0.100) produced at 37°C/60 min, pH 3.5. The aspartic proteinase inhibitor pepstatin had an IC50 of 27 nm when tested in a dose-response study with the purified enzyme. The apparent Ki for pepstatis was 2.9 nm. Several synthetic inhibitors of the enzymes were identified with IC50's in the nanomolar range. The most potent compound, A70450, was characterized as a fast, tight-binding inhibitor having an IC50 of 1.3 nm and apparent Ki of 0.17 nm. © 1992.
引用
收藏
页码:96 / 102
页数:7
相关论文
共 31 条
  • [1] EXPRESSION OF EXTRACELLULAR ACID PROTEINASE BY PROTEOLYTIC CANDIDA SPP DURING EXPERIMENTAL-INFECTION OF ORAL-MUCOSA
    BORG, M
    RUCHEL, R
    [J]. INFECTION AND IMMUNITY, 1988, 56 (03) : 626 - 631
  • [2] SEQUENCE-SPECIFIC FRAGMENTATION FROM OLIGOPEPTIDES USING PLASMA-DESORPTION MASS-SPECTROMETRY
    BUKO, AM
    SARIN, VK
    [J]. RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 1990, 4 (12) : 541 - 545
  • [3] Cleland W W, 1979, Methods Enzymol, V63, P103
  • [4] DEBERNARDIS F, 1990, J INFECT DIS, V161, P1276, DOI 10.1093/infdis/161.6.1276
  • [5] FREY CL, 1990, 90TH ANN M AM SOC MI, P425
  • [6] GHANNOUM M, 1986, J MED VET MYCOL, V24, P407
  • [7] RECOMBINANT HUMAN PRORENIN FROM CHO CELLS - EXPRESSION AND PURIFICATION
    HOLZMAN, TF
    CHUNG, CC
    EDALJI, R
    EGAN, DA
    GUBBINS, EJ
    RUETER, A
    HOWARD, G
    YANG, LK
    PEDERSON, TM
    KRAFFT, GA
    WANG, GT
    [J]. JOURNAL OF PROTEIN CHEMISTRY, 1990, 9 (06): : 663 - 672
  • [8] HUBE B, 1991, J MED VET MYCOL, V29, P129
  • [9] ACTIVATION OF THE PLASMA KALLIKREIN-KININ SYSTEM BY CANDIDA-ALBICANS PROTEINASE
    KAMINISHI, H
    TANAKA, M
    CHO, T
    MAEDA, H
    HAGIHARA, Y
    [J]. INFECTION AND IMMUNITY, 1990, 58 (07) : 2139 - 2143
  • [10] INTERACTION OF HUMAN CATHEPSIN-D WITH INHIBITOR PEPSTATIN
    KNIGHT, CG
    BARRETT, AJ
    [J]. BIOCHEMICAL JOURNAL, 1976, 155 (01) : 117 - 125